EpiBesançon 2022 10&11 May
6th edition of EpiCongress
EpiBesançon 2022 is the 6th edition of international epigenetics congress. This meeting is co-organized by the Niches and Epigenetics of Tumors Network of Canceropole Grand Ouest and the epignetics group of INSERM UMR1098.
This congress is an opportunity for international researchers, PhD students, MD and private industrials to discuss about the development of epigenetic drugs through a better understanding of molecular mechanisms of epigenetics mainly in the ﬁeld of cancer. Thus, communications will be performed with the goal to inform scientiﬁc community about recent and innovative researches in epigenetics in fundamental ﬁeld and also in medicine/clinical applications.
Thus, we expect that this meeting would open the way to new epigenetic projects and promote new collaborations for your future research. After the virtual meeting that have been held in 2021 we are very happy to warmly welcome you in Besançon in May 2022.
Registration is open here ! Click here to register
Then go to Abstract Submission Guidlines if you want to submit a communication! (deadline 1st February 2022)
Anaïs Bardet, Interplay between transcription factors and DNA methylation in cancer, Strasbourg, France
Rachel Deplus, Bruxelles, France (title coming)
Ciro Isidoro, Non-coding RNA epigenetic regulation of autophagy in cancer, Novara, Italy
Carmen Jeronimo, Epigenomics and epitranscriptomics: unravelling urological cancer biology and novel clinical biomarkers, Porto, Portugal
Olivier Joffre, Epigenetic control of T helper cell programming sounds good, Toulouse, France
Hisham Mohammed, Multi-omic single-cell approach reveals transcriptional and epigenetic plasticity in hormone driven cancers Portland, USA
Denis Mottet, The BAF complex: more than a chromatin remodeling complex, Liege, Belgium (to be confirmed)
Marek Mraz, Impact of microenvionmental interactions on the biology of B cells malignancies, Brno, Czech Republic
Peter Mulligan, Regulation of cancer hallmarks by epigenetic reader proteins, Lyon, France
Duncan Odom, Pervasive lesion segregation shapes cancer genome evolution, Heidelberg, Germany
Gilles Salbert, Epigenetic reprogramming of cancer cells, Rennes, France
Petr Svoboda, Small and long non-coding RNAs in mammalian oocytes, Prague, Czech Republic (to be confirmed)
Céline Vallot, Dynamics of repressive epigenome in cancer in response to treatment, Paris, France
Elina Zueva, Paris, France (title coming)